Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers

BACKGROUND: The aim of the study was to explore Fc mutations of a humanised anti-Lewis-Y antibody (IgG1) hu3S193 as a strategy to improve therapeutic ratios for therapeutic payload delivery. METHODS: Four hu3S193 variants (I253A, H310A, H435A and I253A/H310A) were generated via site-directed mutagen...

Descripción completa

Detalles Bibliográficos
Autores principales: Burvenich, Ingrid J. G., Lee, Fook-Thean, O’Keefe, Graeme J., Makris, Dahna, Cao, Diana, Gong, Sylvia, Rigopoulos, Angela, Allan, Laura C., Brechbiel, Martin W., Liu, Zhanqi, Ramsland, Paul A., Scott, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796444/
https://www.ncbi.nlm.nih.gov/pubmed/26983636
http://dx.doi.org/10.1186/s13550-016-0180-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796444/
https://www.ncbi.nlm.nih.gov/pubmed/26983636
http://dx.doi.org/10.1186/s13550-016-0180-0

Ejemplares similares